Fondazione Revert Onlus was born in 2003 with the aim of financing, promoting and encouraging research on brain stem cells and launching clinical trials on humans to find a cure for neurodegenerative diseases, especially Amyotrophic Lateral Sclerosis (ALS) and Multiple Sclerosis (MS).

The foundation’s activity relies on the work by the research team guided by Professor Angelo Luigi Vescovi, who demonstrated how brain stem cell transplantation can really be one of the potentially effective therapies against neurological and neurodegenerative diseases. Angelo Vescovi, Scientific Director of Fondazione Revert Onlus, Scientific Director of IRCCS Casa Sollievo della Sofferenza in San Giovanni Rotondo and Professor of Cell Biology at the Bicocca University in Milan, has devoted his entire career to the research and study of stem cells taking part in international studies and research that have marked important milestones in the field of neuroscience.

Always guided by strong determination, in 1996 he developed a technique for human brain stem cell isolation and culture that paved the way for clinical trials on humans.

The methodology developed by Angelo Vescovi combines advanced scientific research and ethics since the brain stem cells used come exclusively from tissue taken from fetuses that died of natural causes and follows the same authorization and certification procedure as for voluntary organ donation. Prof. Angelo Vescovi states that science has the purpose of understanding, studying, protecting and caring for human life. For this reason, all procedures must respect life and - according to Revert's researchers - life begins exactly at the very moment of fertilization.